Search Results
Onco
Daily
Facebook
RSS
X
Youtube
Linkedin
October, 2024
October 2024
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
« Sep
Piotr Wysocki
Apr 11, 2024, 15:23 |
Drugs
Piotr Wysocki: Adagrasib and cetuximab in KRAS G12C-mutated colorectal cancer is a safe and active
Piotr Wysocki, Professor of Medicine and Head of the Department of Oncology at Jagiellonian University…
Apr 10, 2024, 08:41 |
Drugs
Piotr Wysocki: CAR-T cells targeting CD70 for renal cell cancer – promising results of a phase I COBALT-RCC study (AACR2024)
Piotr Wysocki, Professor of Medicine and Head of the Department of Oncology at Jagiellonian University…
Apr 8, 2024, 16:13 |
Insight
Piotr Wysocki: Incorporation of MRI into prostate cancer screening decreases the risk of overdiagnosis and minimizes the burden of unnecessary systemic biopsies
Piotr Wysocki, Professor of Medicine and Head of the Department of Oncology at Jagiellonian University…
Apr 8, 2024, 14:54 |
Insight
Piotr Wysocki: New data solidify the idea of omitting axillary dissection in breast cancer patients with clinically N0 disease and macrometastases in 1-2 sentinel LN
Piotr Wysocki, Head of the Clinical Oncology Department at Jagiellonian University Hospital, shared on LinkedIn:…
Apr 5, 2024, 08:40 |
Insight
Piotr Wysocki: Vaccination of adult cancer patients - ASCO guidelines
Piotr Wysocki, Professor of Medicine and Head of the Department of Oncology at Jagiellonian University…
Apr 5, 2024, 08:29 |
Drugs
Piotr Wysocki: Promising activity of maintenance olaparib in advanced breast cancer patients responding to platinum-based chemotherapy
Piotr Wysocki, Professor of Medicine and Head of the Department of Oncology at Jagiellonian University…
Mar 29, 2024, 19:49 |
Insight
Piotr Wysocki: There is still no proof that proton beam therapy is superior to IMRT in terms of quality of life in patients with localized prostate cancer
Piotr Wysocki, Professor of Medicine and Head of the Department of Oncology at Jagiellonian University Hospital…
Mar 27, 2024, 10:07 |
Insight
Piotr Wysocki: No benefit of continuing CDK4/6i beyond progression in advanced ER+/HER2- breast cancer
Piotr Wysocki, Professor of Medicine and Head of the Department of Oncology at Jagiellonian University…
Mar 25, 2024, 16:15 |
Insight
Piotr Wysocki: Stereotactic ablative body radiotherapy of primary tumor is highly active in patients with localized renal cell cancer
Piotr Wysocki, Professor of Medicine and Head of the Department of Oncology at Jagiellonian University…
Mar 23, 2024, 04:35 |
Insight
Piotr Wysocki: How can we optimize the endocrine treatment of advanced HR+/HER2- breast cancer?
Piotr Wysocki, Professor of Medicine, Head of Department of Oncology at Jagiellonian University Hospital, recently…
6
7
8
9
10
All:
112
Posts:
71 - 80
ASTRO24: 15 Posts Not To Miss From Day 4
Top 100 Xfluencers in Prostate Cancer: Key Opinion Leaders to follow on X (Twitter) in 2024
Paper Alert! Cutaneous Metastases in Thyroid Cancer: A Comprehensive Review of 136 Cases
ASTRO 24: 15 Posts Not to Miss From Day 3
Gavin Creel: Broadway Icon Dies After Battle with Rare Sarcoma at 48
Special Coverage
ASCO Annual Meeting
May 30 - June 4, 2024
Yvonne Award 2024
May 31, 2024
OncoThon 2024, Online
Feb. 15, 2024
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Facebook
RSS Feed
X
Linkedin
Youtube